Whole Genome Sequence Analysis to Identify SARS-CoV-2 Variant in Nepal

Authors

  • R. Shrestha Department of Pharmacology, Kathmandu University School of Medical Sciences, Dhulikhel, Kavre, Nepal
  • N. Katuwal Research and Development Division, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavre, Nepal
  • N. Adhikari Research and Development Division, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavre, Nepal
  • M. Vanaerschot Chan Zuckerberg Biohub, San Francisco, USA
  • D. Tamrakar Research and Development Division, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavre, Nepal
  • M. Dhimal Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal
  • P. Gyanwali Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal
  • S. Bhattarai Nepal Health Research Council, Ramshah Path, Kathmandu, Nepal
  • S. K. Madhup Department of Microbiology, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Kavre, Nepal
  • B. Devkota Ministry of Health and Population, Kathmandu, Nepal

DOI:

https://doi.org/10.3126/kumj.v19i2.49653

Keywords:

COVID-19, Nepal, SARS-CoV-2, Variant of concern, Whole genome sequencing

Abstract

Background The spread of SARS-CoV-2 has become a global public health crisis. Nepal is facing the second wave of COVID-19 pandemic but, there is still a limited data on the genomic sequence of SARS-CoV-2 variants circulating in Nepal.

Objective The objective of this study is to sequence the whole genome of SARS-CoV-2 in Nepal to detect possible mutation profiles and phylogenetic lineages of circulating SARSCoV- 2 variants.

Method In this study, swab samples tested positive for SARS-CoV-2 were investigated. After RNA extraction, the investigation was performed through real-time PCR followed by whole genome sequencing. The consensus genome sequences were, then, analyzed with appropriate bioinformatics tools.

Result Sequence analysis of two SARS-CoV-2 genomes from patient without travel history (Patient A1 and A2) were found to be of lineage B.1.1. Similarly, among other four samples from subjects returning from the United Kingdom, genomes of two samples were of lineage B.1.36, and the other two were of lineage B.1.1.7 (Alpha Variant). The mutations in the consensus genomes contained the defining mutations of the respective lineages of SARS-CoV-2.

Conclusion We confirmed two genomic sequences of variant of concern VOC-202012/01 in Nepal. Our study provides the concise genomic evidence for spread of different lineages of SARS-CoV-2 – B.1.1, B.1.36 and B.1.1.7 of SARS-CoV-2 in Nepal.

Downloads

Download data is not yet available.
Abstract
54
PDF
89

Downloads

Published

2021-06-30

How to Cite

Shrestha, R., Katuwal, N., Adhikari, N., Vanaerschot, M., Tamrakar, D., Dhimal, M., Gyanwali, P., Bhattarai, S., Madhup, S. K., & Devkota, B. (2021). Whole Genome Sequence Analysis to Identify SARS-CoV-2 Variant in Nepal. Kathmandu University Medical Journal, 19(2), 237–242. https://doi.org/10.3126/kumj.v19i2.49653

Issue

Section

Original Articles